These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 14729088)
1. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088 [TBL] [Abstract][Full Text] [Related]
2. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762 [TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid. Pirouzmand H; Khameneh B; Tafaghodi M Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058 [TBL] [Abstract][Full Text] [Related]
4. PEG-PLA nanoparticles as carriers for nasal vaccine delivery. Vila A; Sánchez A; Evora C; Soriano I; Vila Jato JL; Alonso MJ J Aerosol Med; 2004; 17(2):174-85. PubMed ID: 15294069 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. Gupta NK; Tomar P; Sharma V; Dixit VK Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718 [TBL] [Abstract][Full Text] [Related]
6. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier. Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436 [TBL] [Abstract][Full Text] [Related]
7. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics. Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209 [TBL] [Abstract][Full Text] [Related]
15. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276 [TBL] [Abstract][Full Text] [Related]
16. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain. Hanafy AS; Farid RM; ElGamal SS Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084 [TBL] [Abstract][Full Text] [Related]
17. Chitosan microparticles as oral delivery system for tetanus toxoid. Ahire VJ; Sawant KK; Doshi JB; Ravetkar SD Drug Dev Ind Pharm; 2007 Oct; 33(10):1112-24. PubMed ID: 17852363 [TBL] [Abstract][Full Text] [Related]
18. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery. Shim S; Yoo HS Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260406 [TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928 [TBL] [Abstract][Full Text] [Related]
20. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]